Clinuvel Pharmaceuticals' market value is the price at which a share of Clinuvel Pharmaceuticals trades on a public exchange. It measures the collective expectations of Clinuvel Pharmaceuticals investors about its performance. Clinuvel Pharmaceuticals is trading at 7.70 as of the 26th of December 2025. This is a No Change since the beginning of the trading day. The stock's lowest day price was 7.7. With this module, you can estimate the performance of a buy and hold strategy of Clinuvel Pharmaceuticals and determine expected loss or profit from investing in Clinuvel Pharmaceuticals over a given investment horizon. Check out Clinuvel Pharmaceuticals Correlation, Clinuvel Pharmaceuticals Volatility and Clinuvel Pharmaceuticals Alpha and Beta module to complement your research on Clinuvel Pharmaceuticals.
Please note, there is a significant difference between Clinuvel Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Clinuvel Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Clinuvel Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Clinuvel Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Clinuvel Pharmaceuticals' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Clinuvel Pharmaceuticals.
0.00
12/31/2024
No Change 0.00
0.0
In 11 months and 27 days
12/26/2025
0.00
If you would invest 0.00 in Clinuvel Pharmaceuticals on December 31, 2024 and sell it all today you would earn a total of 0.00 from holding Clinuvel Pharmaceuticals or generate 0.0% return on investment in Clinuvel Pharmaceuticals over 360 days. Clinuvel Pharmaceuticals is related to or competes with Frontage Holdings, Immutep, Northwest Biotherapeutics, Cytodyn, PureTech Health, Cellectis, and Healios KK. Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing and commercializing treatments for ... More
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Clinuvel Pharmaceuticals' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Clinuvel Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for Clinuvel Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Clinuvel Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Clinuvel Pharmaceuticals historical prices to predict the future Clinuvel Pharmaceuticals' volatility.
Clinuvel Pharmaceuticals secures Sharpe Ratio (or Efficiency) of close to zero, which signifies that the company had a close to zero % return per unit of risk over the last 3 months. Clinuvel Pharmaceuticals exposes eighteen different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Clinuvel Pharmaceuticals' Risk Adjusted Performance of 0.0044, mean deviation of 0.879, and Standard Deviation of 2.52 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of -0.33, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Clinuvel Pharmaceuticals are expected to decrease at a much lower rate. During the bear market, Clinuvel Pharmaceuticals is likely to outperform the market. At this point, Clinuvel Pharmaceuticals has a negative expected return of -0.0099%. Please make sure to confirm Clinuvel Pharmaceuticals' jensen alpha, as well as the relationship between the skewness and day typical price , to decide if Clinuvel Pharmaceuticals performance from the past will be repeated at some point in the near future.
Auto-correlation
-0.04
Very weak reverse predictability
Clinuvel Pharmaceuticals has very weak reverse predictability. Overlapping area represents the amount of predictability between Clinuvel Pharmaceuticals time series from 31st of December 2024 to 29th of June 2025 and 29th of June 2025 to 26th of December 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Clinuvel Pharmaceuticals price movement. The serial correlation of -0.04 indicates that only as little as 4.0% of current Clinuvel Pharmaceuticals price fluctuation can be explain by its past prices.
Correlation Coefficient
-0.04
Spearman Rank Test
0.29
Residual Average
0.0
Price Variance
0.17
Clinuvel Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Clinuvel Pharmaceuticals pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Clinuvel Pharmaceuticals' pink sheet expected returns. We can calculate the autocorrelation of Clinuvel Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Clinuvel Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values
Timeline
Clinuvel Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Clinuvel Pharmaceuticals pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Clinuvel Pharmaceuticals pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Clinuvel Pharmaceuticals pink sheet over time.
Current vs Lagged Prices
Timeline
Clinuvel Pharmaceuticals Lagged Returns
When evaluating Clinuvel Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Clinuvel Pharmaceuticals pink sheet have on its future price. Clinuvel Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Clinuvel Pharmaceuticals autocorrelation shows the relationship between Clinuvel Pharmaceuticals pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Clinuvel Pharmaceuticals.
Other Information on Investing in Clinuvel Pink Sheet
Clinuvel Pharmaceuticals financial ratios help investors to determine whether Clinuvel Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Clinuvel with respect to the benefits of owning Clinuvel Pharmaceuticals security.